Literature DB >> 10203285

p53 mutation as a genetic trait of typical medullary breast carcinoma.

P de Cremoux1, A V Salomon, S Liva, R Dendale, B Bouchind'homme, E Martin, X Sastre-Garau, H Magdelenat, A Fourquet, T Soussi.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10203285     DOI： 10.1093/jnci/91.7.641

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  15 in total

1.  Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.

Authors:  Cynthia X Ma; Shirong Cai; Shunqiang Li; Christine E Ryan; Zhanfang Guo; W Timothy Schaiff; Li Lin; Jeremy Hoog; Reece J Goiffon; Aleix Prat; Rebecca L Aft; Matthew J Ellis; Helen Piwnica-Worms
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

2.  Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.

Authors:  Ayyakannu Ayyanan; Gianluca Civenni; Laura Ciarloni; Catherine Morel; Nathalie Mueller; Karine Lefort; Anna Mandinova; Wassim Raffoul; Maryse Fiche; Gian Paolo Dotto; Cathrin Brisken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-24       Impact factor: 11.205

3.  Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures.

Authors:  Hideaki Mizuno; Benjamin T Spike; Geoffrey M Wahl; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

4.  p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.

Authors:  Benjamin T Spike; Geoffrey M Wahl
Journal:  Genes Cancer       Date:  2011-04

5.  Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.

Authors:  A-Yong Cao; Min He; Liang Huang; Zhi-Ming Shao; Gen-Hong Di
Journal:  World J Surg Oncol       Date:  2013-04-22       Impact factor: 2.754

Review 6.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

7.  The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis.

Authors:  Bernard Leroy; Jean Louis Fournier; Chikashi Ishioka; Paola Monti; Alberto Inga; Gilberto Fronza; Thierry Soussi
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

8.  Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray.

Authors:  Ming Lee; Ana Richelia Jara-Lazaro; Poh Yian Cheok; Aye Aye Thike
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

Review 9.  The p53 pathway in breast cancer.

Authors:  Milena Gasco; Shukri Shami; Tim Crook
Journal:  Breast Cancer Res       Date:  2002-02-12       Impact factor: 6.466

10.  Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

Authors:  Anne Vincent-Salomon; Nadège Gruel; Carlo Lucchesi; Gaëtan MacGrogan; Remi Dendale; Brigitte Sigal-Zafrani; Michel Longy; Virginie Raynal; Gaëlle Pierron; Isabelle de Mascarel; Corinne Taris; Dominique Stoppa-Lyonnet; Jean-Yves Pierga; Rémy Salmon; Xavier Sastre-Garau; Alain Fourquet; Olivier Delattre; Patricia de Cremoux; Alain Aurias
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.